To include your compound in the COVID-19 Resource Center, submit it here.

Afinitor everolimus regulatory update

EMA's CHMP issued a positive opinion to extend the indication for Novartis' Afinitor everolimus to include the treatment of

Read the full 199 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE